510(k) device
Coaguchek Xs System
Roche Diagnostics Corp. · Test, Time, Prothrombin (GJS, Class II) · First FDA decision Aug 11, 2006, newest Jan 29, 2007Anemia, clotting and blood disordersStroke prevention in atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
4
Naming "Coaguchek Xs"
MAUDE reports
2,916
Brand "Coaguchek Xs", since 2015
PubMed studies
120
Mentioning "Coaguchek Xs"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Coaguchek Xs System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- COAGUCHEK XS SYSTEM510(k)
K062925 · Decided Jan 29, 2007 · 123 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
- COAGUCHEK XS SYSTEM510(k)
K060978 · Decided Aug 11, 2006 · 123 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Home Prothrombin Time/International Normalized Ratio (PT/INR) Monitoring for Anticoagulation ManagementNational determinationOn the books190.11Updated Nov 4, 2026
- Prothrombin Time (PT)National determinationOn the books190.17Updated Oct 1, 2026
- Prothrombin Time (INR) Monitor for Home Anticoagulation ManagementNational analysisReview closedCAG-00087RUpdated Sep 21, 2026
- Prothrombin Time and Partial Thromboplastin Time (Revision of ICD-9-CM Codes for Swelling of Limb)Coding analysisReview closedCAG-00201NUpdated Sep 15, 2026
- Prothrombin Time and Partial Thromboplastin Time (Revision of ICD-9-CM Codes for Pre-operative Examinations)Coding analysisReview closedCAG-00184NUpdated Sep 15, 2026
- Prothrombin Time and Fecal Occult Blood (Revision of ICD-9-CM Codes for Injury to Gastrointestinal Tract)Coding analysisReview closedCAG-00187NUpdated Sep 15, 2026
- Prothrombin Time (PT) NCD 190.17 (Addition of ICD-9-CM diagnosis code 197.7 Secondary Malignant Neoplasm of Liver)Coding analysisReview closedCAG-00404NUpdated Sep 15, 2026
- Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) tests (Removal of Unspecified Joint Replacements)Coding analysisReview closedCAG-00246NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Coaguchek Xs", any status and sponsor, newest update first.
- Benefit of Self-monitoring of Anticoagulation InstrumentPivotal-lookingCompleted
University Hospital, BordeauxAcademic, hospital or other
NCT00506870 · 919 participants · Start Jun 2007 · Primary completion Feb 2010
Device: INRatio / Coaguchek XS · For: Mechanical Prosthetic Heart Valve Implantation; Patient Self Monitoring of Oral Anticoagulent Therapy
Sites: Pessac, France
Hospital de BaseAcademic, hospital or other
NCT06037720 · 50 participants (planned) · Start Sep 2023 · Primary completion Jan 2024
Device: Coaguchek testing · For: CoaguChek® XS System; Coagulation Function
University of FloridaAcademic, hospital or other
NCT02139072 · 60 participants · Start Mar 2015 · Primary completion Jan 2016
Device: CoaguChek XS · For: Antiphospholipid Antibody Syndrome
Sites: Gainesville, Florida
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Coaguchek Xs", and for the whole product code for context.
This brand
2,916 reports: 2,781 malfunction, 121 injury, 5 death
Whole product code GJS
12,207 reports: 11,507 malfunction, 644 injury, 34 death
Newest reports for this brand
- COAGUCHEK XS PT TEST 6 STRIPMalfunction
1823260-2026-04471 · Received Oct 28, 2026 · Event dated Sep 26, 2026
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Non Reproducible Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- COAGUCHEK XS PT TEST 6 STRIPMalfunction
1823260-2026-04439 · Received Oct 26, 2026 · Event dated Sep 30, 2026
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Non Reproducible Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- CoaguChek XS PT TestMalfunction
1823260-2026-04422 · Received Oct 23, 2026 · Event dated Oct 1, 2026
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Low Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Roche Diagnostics Operations, Inc.
Z-0803-2021 · Started Dec 2, 2020 · Posted by FDA Jan 7, 2021
Reason given: Possible Misinterpretation of Displayed Measuring Units from INR to %Quick or Seconds; providing instructions to users for ensuring the meter is displaying INR results
Cause as FDA categorized it: Device Design · Device type: Test, Time, Prothrombin (GJS)
Roche Diagnostics Operations, Inc.
Z-0804-2021 · Started Dec 2, 2020 · Posted by FDA Jan 7, 2021
Reason given: Possible Misinterpretation of Displayed Measuring Units from INR to %Quick or Seconds; providing instructions to users for ensuring the meter is displaying INR results
Cause as FDA categorized it: Device Design · Device type: Test, Time, Prothrombin (GJS)
Roche Diagnostics Operations, Inc.
Z-1581-2013 · Started May 16, 2013 · Posted by FDA Jun 24, 2013
Reason given: Roche has confirmed the potential for an undetected elevated INR test result with the CoaguChek XS, CoaguChek XS Plus, and CoaguChek XS Pro meters. In rare cases, instead of a value, an ERROR 6 message is displayed.
Cause as FDA categorized it: Software design · Device type: Test, Time, Prothrombin (GJS)
4 more recall records with a free account
Published research
The most relevant PubMed records for "Coaguchek Xs"[tiab]. The summary above synthesizes these.
- CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome.
Fonseca MES, Balbi GGM, Signorelli F, et al. · Lupus · 2022
- Self-management of warfarin therapy.
Sølvik UØ, Løkkebø ES, Kristoffersen AH, et al. · Tidsskr Nor Laegeforen · 2015Comparative Study, Research Support, Non-U.S. Gov't
- Corrigendum to CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome.
Lupus · 2022Published Erratum
- Assessment of the CoaguChek-XS portable prothrombin time point-of-care analyzer for horses.
Berlin N, Kelmer E, Segev G, et al. · J Vet Diagn Invest · 2019
- CoaguChek and Coag-Sense PT2 Meter Point of Care INR Device Validation.
McBane RD, O'Connor C, Lutz J, et al. · Mayo Clin Proc · 2024Multicenter Study, Validation Study
- Evaluating the Effect of Timing on Point-of-Care Testing of INR.
Son J, Kim EM · J Pharm Pract · 2024
- Performance evaluation of coaguchek pro II in comparison with coaguchek XS plus and sta-r Max using a sta-neoplastine CI plus.
Nam M, Hur M, Kim H, et al. · Int J Lab Hematol · 2021Evaluation Study
- Point-of-Care Device for Assessment of Blood Coagulation Status in COVID-19 Patients.
Guest PC, Rahmoune H · Methods Mol Biol · 2022
- Acceptability of CoaguChek S and CoaguChek XS generated international normalised ratios against a laboratory standard in a paediatric setting.
Williams VK, Griffiths AB · Pathology · 2007Comparative Study, Validation Study
- Coagulation testing: Comparison of portable (CoaguChek® XS) and automated coagulation analyzer in healthy cats.
Tonthong S, Rungpupradit J · Vet World · 2020
- Clinical effects of calibration of CoaguChek XS PT Test Strips on Anticoagulation Management Services.
Trautsch M, Nickerson-Troy J, Moore R, et al. · J Am Pharm Assoc (2003) · 2020
- Reliability of point-of-care coagulometer measurements in patients with acute ischaemic stroke receiving intravenous fibrinolysis.
Guisado-Alonso D, Fayos-Vidal F, Martí-Fàbregas J, et al. · Neurologia (Engl Ed) · 2020Observational Study
Other devices of this type
Also filed under product code GJS.
- microINR SystemIline Microsystems, S.L. · 510(k) 2025
- CoaguChek XS Plus SystemRoche Diagnostics · 510(k) 2025
- Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-TestingCoagusense, Inc. · 510(k) 2022
- CoaguChek XS Pro SystemRoche Diagnostics · 510(k) 2018
- Hemosil Recombiplastin 2G (8 Ml Vial)Instrumentation Laboratory CO · 510(k) 2014
- Xprecia Prime Coagulation SystemUniversal Biosensors Pty, Ltd. · 510(k) 2024
- i-STAT PTplus Cartridge with the i-STAT 1 SystemAbbott Laboratories · 510(k) 2023
- STA- NeoPTimalDiagnostica Stago S.A.S · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.